Interestingly, acquisition of the DAM phenotype was shown to be biphasic and dependent in part on Triggering Receptor on Myeloid Cells 2 (Trem2), a well-established genetic risk factor for AD (Gratuze et al., 2018). This evidence concerns the gene TREM2 and Alzheimer disease.